Stockscreener 앱 받기
32.52
0.40%
-0.168
전일 마감가:
$32.69
열려 있는:
$32.87
하루 거래량:
169.37K
Relative Volume:
0.34
시가총액:
$1.62B
수익:
$447.57M
순이익/손실:
$-38.92M
주가수익비율:
-39.18
EPS:
-0.83
순현금흐름:
$-1.15M
1주 성능:
-10.18%
1개월 성능:
-17.76%
6개월 성능:
+15.42%
1년 성능:
-4.21%
1일 변동 폭
$32.49
$33.69
1주일 범위
$32.49
$36.15
52주 변동 폭
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
ATRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.52 | 1.62B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
480.10 | 171.84B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
224.41 | 64.03B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
87.37 | 43.91B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
218.80 | 32.15B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.71 | 17.46B | 17.28B | 108.00M | 391.00M | 0.20 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - StockTitan
AtriCure, Inc. to Host Earnings Call - ACCESS Newswire
AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World
Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada
Atricure Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Karen Prange Sells 6,100 Shares of AtriCure Inc (A - GuruFocus.com
Atricure director Karen Prange sells $232,531 in stock - Investing.com India
Insider Buying: Chief Technical Officer Salvatore Privitera Acqu - GuruFocus.com
Rhumbline Advisers Has $2.41 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
AtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call Transcript - MSN
26,035 Shares in AtriCure, Inc. (NASDAQ:ATRC) Acquired by AlphaCentric Advisors LLC - MarketBeat
HighMark Wealth Management LLC Has $2.56 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 20.4% - MarketBeat
Stifel Nicolaus Raises AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat
AtriCure (NASDAQ:ATRC) Price Target Raised to $45.00 at Oppenheimer - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Down 5.8%Here's What Happened - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock - MarketBeat
AtriCure (NASDAQ:ATRC) Announces Earnings Results - MarketBeat
AtriCure (ATRC) Expected to Announce Earnings on Thursday - MarketBeat
AtriCure's (ATRC) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
AtriCure targets $517M-$527M revenue in 2025 with new product launches and international growth - MSN
Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS - MSN
(ATRC) Technical Pivots with Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at JPMorgan Chase & Co. - MarketBeat
Atricure Files For Mixed Shelf; Size Not DisclosedSEC Filing -February 14, 2025 at 03:53 pm EST - Marketscreener.com
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know - MSN
AtriCure Inc. (ATRC) reports earnings - Quartz
AtriCure, Inc. SEC 10-K Report - TradingView
WCM Investment Management LLC Sells 23,785 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Silver Oak Securities Incorporated Invests $220,000 in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips By Investing.com - Investing.com Australia
AtriCure’s Earnings Call Highlights Strong Growth and Positive Outlook - TipRanks
AtriCure (NASDAQ:ATRC) Earns Market Outperform Rating from JMP Securities - MarketBeat
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates - MSN
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips - MSN
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
0.38%
자본화:
|
볼륨(24시간):